Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin KangNaiEr Pharmaceutical is a Chinese pharmaceutical company based in the Changchun High-tech Industrial Development Zone. Founded in 2003, the company specializes in the development and large-scale manufacturing of chemical pharmaceuticals and traditional Chinese medicine (TCM) products. Its portfolio includes a variety of essential medicines such as antibiotics, cardiovascular agents, and respiratory treatments in multiple dosage forms. The company operates under strict GMP standards to ensure the quality of its oral solids and sterile injections. Jilin KangNaiEr primarily focuses on the domestic healthcare market in China, providing cost-effective therapeutic options.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin KangNaiEr.